Clinical trial
Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction…
NCT00295672 · University Hospital, Brest, Other · Completed
Key facts
| NCT number | NCT00295672 |
|---|---|
| Title | Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC. |
| Official title | Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy With Cisplatin-docetaxel in Patients With Locally Advanced Non-small-cell Lung Cancer. A Multicenter Phase II Trial |
| Acronym | VINCR |
| Lead sponsor | University Hospital, Brest, Other |
| Collaborators | Fabre Clinic |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Neoplasm |
| Intervention type | Drug |
| Interventions | Vinorelbine |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Feb 24, 2006 |
| Last update posted | Jul 28, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: